Nymox Pharmaceutical Corporation

The momentum for this stock is not very good. Nymox Pharmaceutical Corporation is not very popular among insiders. Tradey thinks it is not wise to invest in Nymox Pharmaceutical Corporation.
Log in to see more information.
Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and...

News

NYMX Tanks after Receiving Delisting Notice
NYMX Tanks after Receiving Delisting Notice

TipRanks Financial Blog Nymox Pharmaceuticals (NASDAQ: NYMX) tanked in pre-market trading at the time of writing on Thursday after the company received a potential Nasdaq delisting notice....\n more…

Nymox Pharmaceutical receives potential delisting notice from Nasdaq
Nymox Pharmaceutical receives potential delisting notice from Nasdaq

SeekingAlpha.com: All News Nymox Pharmaceutical (NYMX) informed shareholders on Wednesday that it has received a delisting determination letter from Nasdaq on failing to regain with the minimum bid...\n more…

Nymox Delisting from NASDAQ
Nymox Delisting from NASDAQ

Globe Newswire IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the Company) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq, and hence the ...\n more…

Nymox Pharmaceutical (NASDAQ:NYMX) Coverage Initiated by Analysts at StockNews.com
Nymox Pharmaceutical (NASDAQ:NYMX) Coverage Initiated by Analysts at StockNews.com

Ticker Report StockNews.com began coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX Free Report) in a research report report published on Monday morning. The firm issued a sell rating on the biopharmaceutical companys stock. Nymox Pharmaceutical Stock Up 37.8 % Shares of NASDAQ NYMX opened at...\n more…

Nymox Pharmaceutical (NASDAQ:NYMX) Receives New Coverage from Analysts at StockNews.com
Nymox Pharmaceutical (NASDAQ:NYMX) Receives New Coverage from Analysts at StockNews.com

Zolmax StockNews.com started coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX Get Rating) in a research note issued on Sunday. The brokerage set a sell rating on the biopharmaceutical companys stock. Nymox Pharmaceutical Stock Performance NYMX opened at $0.33 on Friday. The firms 50-day simple ...\n more…

Nymox Pharmaceutical (NASDAQ:NYMX) Receives New Coverage from Analysts at StockNews.com
Nymox Pharmaceutical (NASDAQ:NYMX) Receives New Coverage from Analysts at StockNews.com

Ticker Report StockNews.com started coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX Get Rating) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biopharmaceutical companys stock. Nymox Pharmaceutical Stock Performance NYMX opened at $0.32 on ...\n more…